当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析

贝达药业

(300558)

  

流通市值:236.37亿  总市值:237.13亿
流通股本:4.19亿   总股本:4.21亿

贝达药业(300558)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.31亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益567747.87万元,未分配利润268084.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产919936.82万元,负债352188.95万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,731,412,742.27917,554,506.922,891,950,112.032,344,643,009.24
营业总成本1,494,357,686.84730,520,724.152,460,400,758.661,978,236,019.16
其他经营收益
营业利润188,147,769.79123,067,237.11399,871,684.57438,271,814.06
利润总额187,816,069.23123,152,668.55394,158,101.64431,823,507.59
净利润130,707,401.195,463,516.48386,979,402.58405,153,844.02
每股收益
其他综合收益-148,106,979.63-137,880,994.1556,915,948.89-32,146,129.61
综合收益总额-17,399,578.53-42,417,477.67443,895,351.47373,007,714.41
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,358,719,685.231,301,717,893.561,224,330,599.971,526,566,689.45
非流动资产:
非流动资产合计7,840,648,525.127,823,800,408.48,117,347,123.847,831,405,379.98
资产总计9,199,368,210.359,125,518,301.969,341,677,723.819,357,972,069.43
流动负债:
流动负债合计1,756,546,635.12,092,412,147.121,847,959,887.481,776,897,468.14
非流动负债:
非流动负债合计1,765,342,827.011,401,806,555.711,827,607,601.771,854,963,323.22
负债合计3,521,889,462.113,494,218,702.833,675,567,489.253,631,860,791.36
所有者权益(或股东权益):
归属于母公司股东权益合计5,594,364,394.565,543,677,139.015,573,806,060.135,636,950,298.89
股东权益合计5,677,478,748.245,631,299,599.135,666,110,234.565,726,111,278.07
负债和股东权益合计9,199,368,210.359,125,518,301.969,341,677,723.819,357,972,069.43
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,818,979,709.29968,760,882.263,219,792,5912,548,182,394.1
经营活动现金流出小计1,374,001,421.08671,225,194.252,308,620,414.781,716,841,655.31
经营活动产生的现金流量净额444,978,288.21297,535,688.01911,172,176.22831,340,738.79
投资活动产生的现金流量:
投资活动现金流入小计14,509.42100,00031,722,710.162,050,815.97
投资活动现金流出小计391,306,234.66192,857,786.751,033,415,672.65783,733,321.62
投资活动产生的现金流量净额-391,291,725.24-192,757,786.75-1,001,692,962.49-781,682,505.65
筹资活动产生的现金流量:
筹资活动现金流入小计672,166,278150,000,000644,750,000483,600,000
筹资活动现金流出小计670,150,013.23178,190,846.43836,133,783.9683,894,076.8
筹资活动产生的现金流量净额2,016,264.77-28,190,846.43-191,383,783.9-200,294,076.8
汇率变动对现金及现金等价物的影响-196,210.48-133,207.851,590,510.79-6,019,687.56
现金及现金等价物净增加额55,506,617.2676,453,846.98-280,314,059.38-156,655,531.22
期末现金及现金等价物余额527,189,472.38548,136,702.1471,682,855.12595,341,383.28
补充资料:
现金及现金等价物的净增加额55,506,617.26--280,314,059.38-
最新报告期:2025-09-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券曹泽运,祝嘉琦1.462.202.702025-09-25
天风证券杨松,曹文清1.371.772.032025-09-15
西南证券杜向阳1.301.231.312025-08-26
东海证券杜永宏1.121.401.782025-08-26
中金公司张琎,刘雅馨,朱言音1.722.18--2025-08-26
TOP↑